Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Myeloid-derived suppressor cells in glioma

Dendritic cell-based immunotherapy in ovarian cancer

Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation